Stockscreener 앱 받기
0.2946
5.50%
0.0112
Co Diagnostics Inc 주식(CODX)의 최신 뉴스
What drives Co Diagnostics Inc. stock priceExponentially increasing returns - jammulinksnews.com
What analysts say about Co Diagnostics Inc. stockFree AI-Backed Trading Signals - Autocar Professional
Co Diagnostics Inc. Stock Analysis and ForecastSkyrocketing investment returns - printweek.in
Is Co Diagnostics Inc. a good long term investmentExceptional profit velocity - jammulinksnews.com
Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025 - Yahoo
Why Co Diagnostics Inc. stock attracts strong analyst attentionGroup Only Stock Signals - Newser
What makes Co Diagnostics Inc. stock price move sharplyFree Day Trading Recommendations - Newser
How Co Diagnostics Inc. stock performs during market volatilityFree Predictions - Newser
Co-Diagnostics to showcase PCR diagnostics at WHX Kuala Lumpur. - AInvest
Co-Diagnostics Unveils Next-Gen PCR Platform at Southeast Asia's Largest Healthcare Expo, Clinical Trials Coming - Stock Titan
Co-Diagnostics Granted NASDAQ Grace Period Extension - The Globe and Mail
Co-Diagnostics, Inc. to Host Booth at Medical Fair Asia 2022 in Singapore on Aug 31-Sep 2 - MarketScreener
Co-Diagnostics Inc (CODX) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Co-Diagnostics (NASDAQ:CODX) and CareDx (NASDAQ:CDNA) Head to Head Analysis - Defense World
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys, Deadline Approaching in Securities Class Action - ACCESS Newswire
CODX INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm - ACCESS Newswire
Co-Diagnostics, Inc. (NASDAQ:CODX) Short Interest Up 19.5% in May - Defense World
Co-Diagnostics completes first FDA 510(k) application for Co-Dx PCR Pro - TipRanks
Co-Diagnostics Holds Annual Shareholders Meeting - TipRanks
Co-Diagnostics stock hits 52-week low at $0.27 amid market challenges - Investing.com Australia
Major health care company files for bankruptcy to sell assets - TheStreet
HC Wainwright Predicts Co-Diagnostics Q1 Earnings - Defense World
Q2 EPS Estimates for Co-Diagnostics Raised by HC Wainwright - Defense World
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference | CODX Stock News - GuruFocus
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference - The Manila Times
Co-Diagnostics, Inc. to Participate in D. Boral Capital Inaugural Global Conference on May 14, 2025 - Nasdaq
Co-Diagnostics Unveils Next-Gen PCR Testing Platform to Elite Institutional Investors - Stock Titan
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Co-Diagnostics Q1 2025 shows improved EPS and revenue decline - Investing.com Nigeria
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Stra - GuruFocus
Co-Diagnostics Q1 2025 Earnings Call Transcript - MarketBeat
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid Revenue ... - Yahoo Finance
AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Completion of Sample Set for the Strategic Partnership Implemented to Advance Biomarker Development for Alzheimer’s Disease and Neurodegeneration - Business Wire
Co-Diagnostics Reports Q1 2025 Financial Results - TipRanks
Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue Estimates - MSN
1.21%
0.51%
자본화:
|
볼륨(24시간):